Why Summit Therapeutics Stock Soared 8% Higher Today
This could be worth up to $15 billion in total, according to a media report.
10 stocks we like better than Summit Therapeutics ›
One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped by 8%, on a media report that a well-known peer was interested in a licensing deal. That rise bettered the S&P 500's (SNPINDEX: ^GSPC) 0.8% increase by several orders of magnitude.
The media outlet in question was Bloomberg, which that morning published an article asserting that AstraZeneca is in talks with Summit about a partnership between the two companies.
According to unnamed "people familiar with the matter," the piece stated that such a partnership would center on the investigational lung cancer treatment ivonescimab. The drug, which Summit licenses from Chinese peer Akeso, has recently attracted much attention from the healthcare community and investors alike. This was due to its impressive performance in a late-stage clinical trial.
Bloomberg's sources said that the terms of a potential deal were still being hashed out. They might include an up-front payment of several billion dollars, and several milestone payments over time (this kind of structure is common in pharmaceutical industry licensing/partnership arrangements). All told, a deal between the two companies could pay out as much as $15 billion.
Both Summit and AstraZeneca declined comment on the Bloomberg article.
When a drug development program attracts $15 billion worth of interest from a major industry player with deep pockets, it's almost indisputably a win. If the Bloomberg report is accurate and a deal is indeed in the works (and is ultimately agreed upon), it would open a great, powerful, and quick road to success for Summit. It's little wonder investors were so happy about the possibility.
Before you buy stock in Summit Therapeutics, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Summit Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $692,914!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $963,866!*
Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 30, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.
Why Summit Therapeutics Stock Soared 8% Higher Today was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
2 Elite S&P 500 Dividend Stocks to Buy Now and Hold Forever
Constellation Brands sells some of the most popular imported beers, but the stock can be bought for a song right now. Home Depot still commands a small share of the home improvement market, making it an excellent dividend growth stock. 10 stocks we like better than Constellation Brands › It's nice to have cash deposited automatically deposited into your investment account on a regular basis. The S&P 500 (SNPINDEX: ^GSPC) includes some of the largest and best businesses in the world, and many of these companies can make solid income investments. Here are two S&P 500 companies that are offering much higher yields than the index's 1.21% average. Imported beer makes up nearly a fifth of all beer consumed in the U.S., according to the Beer Institute, and Constellation Brands (NYSE: STZ) is the top seller and importer of three of the top imported beers in the U.S.: Modelo, Pacifico, and Corona. Recent sales weakness due to macroeconomic issues has sent the stock down, but the company generates plenty of earnings to support growing dividends. Constellation Brands is paying out close to a third of its adjusted earnings in dividends. Its quarterly payment is $1.02, which increased this year by $0.01. This puts the stock's forward dividend yield at an attractive 2.37%. Top beverage makers like Constellation Brands can make great income investments. While sales can soften when consumer spending trends weaken, these companies are selling an affordable product that people consume throughout the year. This leads to stable sales, earnings, and dividends. Constellation has been paying a growing dividend since 2015. Beer makes up the far majority of the company' business, but it also generates a small amount of sales from wine and spirits. However, management has sold off some wine assets recently to improve the performance of that side of the business. Management is aiming to save more than $200 million annually in costs by fiscal 2028. This spells more earnings and dividend increases for shareholders. While the stock was falling this year, Constellation's beer business remained the top market share gainer in the first quarter, with six of the top 15 dollar share-gaining beer brands in the U.S. This makes the recent dip in the share price a good buying opportunity. The lower share price has brought the forward price-to-earnings multiple down to a cheap 13.6 at the time of writing. Management is still guiding for full-year adjusted earnings per share between $12.60 to $12.90. Investors not only get the benefit of the above-average dividend yield but could see a nice return on the stock over the next five years. Home Depot (NYSE: HD) is the world's largest home improvement retailer with 2,350 stores across the U.S., Puerto Rico, the U.S. Virgin Islands, Guam, Canada, and Mexico. Like Constellation Brands, Home Depot has experienced soft sales over the past year. However, the stock has held up quite well and could surge to new highs if interest rates come down. The stock is currently offering an attractive forward yield of 2.48%. Tariffs on imported goods raised concerns about the potential for higher inflation, but so far, inflation has been relatively muted. The longer this continues, the greater the chance the Federal Reserve will lower interest rates, which would make financing home projects more affordable and benefit Home Depot. The long-term trend of growing household net worth is a secular tailwind that has made Home Depot a solid growth stock, on top of its growing dividend. A $10,000 investment in the stock 20 years ago would be worth $107,000 today, or $176,000 including dividend reinvestment. Home Depot has paid 38 consecutive years of dividend payments, which are well covered by earnings. The company paid 61% of earnings in dividends to shareholders over the past year. It raised its quarterly dividend earlier this year by 2% to $2.30. Home Depot generates $162 billion in annual sales but is going after a $1 trillion addressable market in home improvement. It has a solid competitive position in an important segment of the economy that should lead to many more years of growing dividend payments. Before you buy stock in Constellation Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Constellation Brands wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Home Depot. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy. 2 Elite S&P 500 Dividend Stocks to Buy Now and Hold Forever was originally published by The Motley Fool
Yahoo
23 minutes ago
- Yahoo
Attention, Nvidia Shareholders: 1 Crucial Thing to Watch in the Second Half
Nvidia, after early headwinds, finished the first half of the year with a gain. The company reached a new milestone in recent days, one that could set the tone for share performance in the second half. 10 stocks we like better than Nvidia › The first half was a bit of a roller coaster ride for Nvidia (NASDAQ: NVDA) shareholders. The stock slid almost 30% from the start of the year to early April amid a variety of concerns -- from the future of artificial intelligence (AI) spending to worries that President Trump's import tariffs would weigh on the economy and corporate earnings. Meanwhile, the company continued to launch its new Blackwell platform and delivered double-digit quarterly revenue growth. The message for future prospects is bright too, with Nvidia speaking of soaring demand in the area of AI inference and launching projects abroad such as the building of AI infrastructure in Abu Dhabi. All of this, along with an easing of international trade tensions, prompted investors to return to growth stocks, and one of their top picks has been Nvidia -- the stock finished the first half with a 17% gain. Now, as we head into the second half of the year, you may be wondering how Nvidia will fare -- here's one crucial element to watch. Nvidia has built an amazing success story over the years, transforming itself from a company that mainly served the video gaming market to one that's at the center of one of today's highest growth industries. The graphic processing unit (GPU) still is integral to video games, but Nvidia -- thanks to sales of GPUs and related products and services -- today generates most of its revenue from AI customers. For example, in the latest quarter, data center revenue made up 88% of total revenue. This AI giant entered the AI market in its earliest days and aggressively built an empire. Today, selling the world's top-performing GPUs, Nvidia dominates the AI chip market and has pledged to update its chips -- and often complete architecture -- on an annual basis. It launched this annual rhythm with the Blackwell architecture and chip in the fourth quarter of last year -- the rollout went smoothly, Nvidia maintained gross margin in its forecast range, and Blackwell delivered $11 billion in revenue during its first quarter of commercialization. That represented a successful start to this fast-paced innovation plan, and this brings me to the point to watch now -- a new milestone for Nvidia -- as the second half begins. Nvidia's next launch is Blackwell Ultra, and it's already started as cloud player CoreWeave just announced the availability of the platform. CoreWeave now is offering customers access to GB300 NVL72, a system that's a step up from the original Blackwell and a leap from the Hopper architecture -- that was the main Nvidia architecture in use before the original Blackwell launch this winter. GB300 NVL72 may provide a fiftyfold jump in output for reasoning model inference compared to Hopper. Now, the point to watch is this Blackwell Ultra rollout, with special attention to demand and whether the process is smooth or not. And once earnings season rolls around, it will be important to look at sales figures as well as gross margin. If this latest update mirrors the Blackwell launch, investors may have something to cheer about -- and we'll have reason to be optimistic about the next chip launches too. Nvidia will have proved its ability to successfully handle frequent chip releases and maintain strong growth and profitability on sales. If there's a glitch along the way or if Nvidia misses a financial goal, then it will be important to dig deeper and examine whether this was just a one-time problem or something that could persist through the next product launches. This is crucial for Nvidia because its market leadership depends on this ability to innovate and successfully roll out a new product. Demand for Blackwell this winter, with it exceeding supply at certain moments, shows us customers are eager to get their hands on the next Nvidia innovation. That's positive, but Nvidia must smoothly deliver on promises in order to keep this momentum going. So far, with the Blackwell launch as a reference point, there's reason to be optimistic. And if Nvidia scores a win with the Blackwell Ultra launch too, the company could see its stock continue to march higher in the second half. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Attention, Nvidia Shareholders: 1 Crucial Thing to Watch in the Second Half was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Cathie Wood's Tesla Bet Pays Off Again. But How Long Can It Last?
Tesla is part of the Magnificent Seven. The stock has richly rewarded long-term investors. The company faces significant challenges, however. These 10 stocks could mint the next wave of millionaires › Cathie Wood, CEO of Ark Invest, oversees numerous exchange-traded funds (ETFs), including a family of funds that invest in technology stocks. These funds have had some success in the past, with the Ark Innovation ETF (NYSEMKT: ARKK), the largest one under the company's umbrella, returning nearly 60% over the past year through June 30. That's nearly four times the Nasdaq Composite's 15.7% return during that time. But the fund isn't necessarily for the faint of heart, given its concentration in the tech sector. It seeks to invest in companies at the forefront of "disruptive innovation. One of the Ark Innovation ETF's biggest winners has been Tesla (NASDAQ: TSLA). As of July 2, the fund owned about 2.1 million shares of the electric vehicle (EV) maker. That stake, worth over $630 million, represented 9.6% of the fund's assets, making it the ETF's biggest position. But can Tesla continue to rocket upwards, or is it due for a crash landing? Tesla, one of the "Magnificent Seven" group of technology stocks, has produced strong returns for shareholders. In 2024, the stock gained 62.5%, easily besting the S&P 500's total return of 25% and the Nasdaq Composite's total return of 29.6%. Tesla's automotive business produces most of the company's revenue. In 2024, this fell 6% to $77.1 billion due in part to lower EV prices. Including services (e.g., used vehicles, maintenance services, supercharging, and insurance), the top line from that segment dropped 3% to $87.6 billion. Its other major revenue source is the energy generation and storage segment, which was a bright spot. That business includes selling, leasing, and financing solar energy generation and storage products, and it saw a 67% increase in revenue to $10.1 billion. However, it made up only about 10% of Tesla's total revenue. Arguably, Elon Musk's relationship with Donald Trump, both during the campaign and his presidency, likely contributed to the stock price growth last year. But Musk and Trump have had a falling out, and it's difficult to analyze a company's long-term prospects based on personal relationships with politicians. The stock has lost 21.9% this year through July 2, badly lagging the S&P 500, which has gained 6.8%. Additionally, portions of the Republicans' recently passed tax and spending bill would seem to hurt Tesla's prospects. The new law eliminates the federal tax credits for electric vehicles and solar energy systems, which makes those products more expensive for consumers. Tesla was already facing challenges, including China-based EV giant BYD (OTC: BYDD.F) (OTC: BYDDY), which has been slashing its prices. The fierce competition has negatively affected Tesla's results. Tesla will report its second-quarter results at the end of the month, but its first-quarter automotive revenue dropped by 20% to $14 billion. That results in a total top-line drop of 9%, and its operating income under generally accepted accounting principles (GAAP) fell by 66% to $399 million. Management has already published its second-quarter vehicle delivery numbers, which showed that its sales remain under pressure. It delivered about 384,000 cars in Q2, compared to over 422,000 in the prior-year period. Management has been investing in new technologies and products, like the fully autonomous Cybercab, which is scheduled to go into production next year. There's a potentially large market for such vehicles, and for the robotaxi service Tesla intends to build, but it's one fraught with challenges. The race to autonomous driving has seen a number of false starts from other companies. It's hard to bet against a Musk-run company given the success he's had in his various ventures. However, given the challenges Tesla faces and its high valuation -- it trades today at a price-to-sales ratio of 11.6 and a price-to-earnings ratio of 173 -- I'd stay away from the stock. And for investors in the Ark Innovation ETF, I wouldn't expect the EV stock to be the biggest positive driver of the fund's future returns. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $413,238!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $40,540!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $699,558!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of July 7, 2025 Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool recommends BYD Company. The Motley Fool has a disclosure policy. Cathie Wood's Tesla Bet Pays Off Again. But How Long Can It Last? was originally published by The Motley Fool
